Vorinostat

In the US, Vorinostat (vorinostat systemic) is a member of the drug class histone deacetylase inhibitors and is used to treat Cutaneous T-cell Lymphoma.

US matches:

• Vorinostat

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX38

CAS registry number (Chemical Abstracts Service)

0149647-78-9

Chemical Formula

C14-H20-N2-O3

Molecular Weight

264

Therapeutic Categories

Anti-inflammatory agent

Antineoplastic agent

Enzyme inhibitor

Chemical Names

N-hydroxy-N'-phenyloctanediamide (WHO)

Korksäure-anilid-Hydroxamsäure

Octandisäure hydroxyamid phenylamid (IUPAC)

Octanediamide, N-hydroxy-N'-phenyl-

Suberoylanilide hydroxamic acid

Foreign Names

• Vorinostatum (Latin)
• Vorinostat (German)
• Vorinostat (French)
• Vorinostat (Spanish)

Generic Names

• Vorinostat (OS: USAN)
• CCRIS 8456 (IS)
• MK-0683 (IS: Merck)
• SAHA (IS)
• SAHA cpd (IS)

Brand Name

• Zolinza
  Merck, United States

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.